CLINICAL TRIALS PROFILE FOR AZD1390
✉ Email this page to a colleague
Clinical Trials for AZD1390
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT03215381 ↗ | AZD1390 Administration of a Microdose [11C]AZD1390 to Healthy Volunteers | Completed | Karolinska Institutet, Quintiles IMS | Phase 1 | This is an open-label, single centre exploratory study to analyse brain exposure of AZD1390 in healthy volunteer males. |
NCT03215381 ↗ | AZD1390 Administration of a Microdose [11C]AZD1390 to Healthy Volunteers | Completed | AstraZeneca | Phase 1 | This is an open-label, single centre exploratory study to analyse brain exposure of AZD1390 in healthy volunteer males. |
NCT03423628 ↗ | A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer | Recruiting | AstraZeneca | Phase 1 | This study will test an investigational drug called AZD1390 in combination with radiation therapy for the treatment of brain tumors. This is the first time AZD1390 is being given to patients. This study will test safety, tolerability and PK (how the drug is absorbed, distributed and eliminated) of ascending doses of AZD1390 in combination with distinct regimens of radiation therapy |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for AZD1390
Condition Name
Clinical Trial Locations for AZD1390
Trials by Country
Clinical Trial Progress for AZD1390
Clinical Trial Phase
Clinical Trial Sponsors for AZD1390
Sponsor Name